Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify sm...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0210869 |
id |
doaj-09805d18963c4b51980b147b1e2df79b |
---|---|
record_format |
Article |
spelling |
doaj-09805d18963c4b51980b147b1e2df79b2021-03-03T20:56:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01141e021086910.1371/journal.pone.0210869Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.Maywan HarionoSy Bing ChoiRos Fatihah RoslimMohamed Sufian NawiMei Lan TanEzatul Ezleen KamarulzamanNornisah MohamedRohana YusofShatrah OthmanNoorsaadah Abd RahmanRozana OthmanHabibah A WahabDengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify small molecules inhibitor from National Cancer Institute database through virtual screening. One of the hits, D0713 (IC50 = 62 μM) bearing thioguanine scaffold was derivatised into 21 compounds and evaluated for DENV-2 NS2B/NS3 protease inhibitory activity. Compounds 18 and 21 demonstrated the most potent activity with IC50 of 0.38 μM and 16 μM, respectively. Molecular dynamics and MM/PBSA free energy of binding calculation were conducted to study the interaction mechanism of these compounds with the protease. The free energy of binding of 18 calculated by MM/PBSA is -16.10 kcal/mol compared to the known inhibitor, panduratin A (-11.27 kcal/mol), which corroborates well with the experimental observation. Results from molecular dynamics simulations also showed that both 18 and 21 bind in the active site and stabilised by the formation of hydrogen bonds with Asn174.https://doi.org/10.1371/journal.pone.0210869 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maywan Hariono Sy Bing Choi Ros Fatihah Roslim Mohamed Sufian Nawi Mei Lan Tan Ezatul Ezleen Kamarulzaman Nornisah Mohamed Rohana Yusof Shatrah Othman Noorsaadah Abd Rahman Rozana Othman Habibah A Wahab |
spellingShingle |
Maywan Hariono Sy Bing Choi Ros Fatihah Roslim Mohamed Sufian Nawi Mei Lan Tan Ezatul Ezleen Kamarulzaman Nornisah Mohamed Rohana Yusof Shatrah Othman Noorsaadah Abd Rahman Rozana Othman Habibah A Wahab Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. PLoS ONE |
author_facet |
Maywan Hariono Sy Bing Choi Ros Fatihah Roslim Mohamed Sufian Nawi Mei Lan Tan Ezatul Ezleen Kamarulzaman Nornisah Mohamed Rohana Yusof Shatrah Othman Noorsaadah Abd Rahman Rozana Othman Habibah A Wahab |
author_sort |
Maywan Hariono |
title |
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. |
title_short |
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. |
title_full |
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. |
title_fullStr |
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. |
title_full_unstemmed |
Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. |
title_sort |
thioguanine-based denv-2 ns2b/ns3 protease inhibitors: virtual screening, synthesis, biological evaluation and molecular modelling. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify small molecules inhibitor from National Cancer Institute database through virtual screening. One of the hits, D0713 (IC50 = 62 μM) bearing thioguanine scaffold was derivatised into 21 compounds and evaluated for DENV-2 NS2B/NS3 protease inhibitory activity. Compounds 18 and 21 demonstrated the most potent activity with IC50 of 0.38 μM and 16 μM, respectively. Molecular dynamics and MM/PBSA free energy of binding calculation were conducted to study the interaction mechanism of these compounds with the protease. The free energy of binding of 18 calculated by MM/PBSA is -16.10 kcal/mol compared to the known inhibitor, panduratin A (-11.27 kcal/mol), which corroborates well with the experimental observation. Results from molecular dynamics simulations also showed that both 18 and 21 bind in the active site and stabilised by the formation of hydrogen bonds with Asn174. |
url |
https://doi.org/10.1371/journal.pone.0210869 |
work_keys_str_mv |
AT maywanhariono thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT sybingchoi thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT rosfatihahroslim thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT mohamedsufiannawi thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT meilantan thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT ezatulezleenkamarulzaman thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT nornisahmohamed thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT rohanayusof thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT shatrahothman thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT noorsaadahabdrahman thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT rozanaothman thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling AT habibahawahab thioguaninebaseddenv2ns2bns3proteaseinhibitorsvirtualscreeningsynthesisbiologicalevaluationandmolecularmodelling |
_version_ |
1714819600981426176 |